Published in Cancer Weekly, January 24th, 2012
"Selective inhibition of CMA slows tumor growth, boosts tumor cell death, and induces the regression of existing tumors," wrote A. Thorburn and colleagues, University of Colorado.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.